Rilotumumab Completed Phase 2 Trials for Glioblastoma Multiforme (GBM) / Gliosarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01113398AMG 102 and Avastin for Recurrent Malignant Glioma